Respiratory system cancer is a group of cancers that start in the lungs or other parts of the airways, and it can affect breathing and daily activity. Early symptoms of respiratory system cancer can include a lasting cough, coughing up blood, chest pain, shortness of breath, or unexplained weight loss. It is most often diagnosed in adults, especially older adults, but not everyone will have the same experience. Respiratory system cancer can be life-threatening, and the outlook depends on the type, stage, and how well treatment works. Treatment often includes surgery, radiation, chemotherapy, targeted medicine, immunotherapy, or a mix of these.
How many people live with Respiratory system cancer?
Because “respiratory system cancer” is a broad label and there is no single standard count for all of these cancers combined, sources usually report the numbers separately, especially for lung cancer and cancer in the main breathing tubes. For that largest and most commonly tracked part of the group, about 3 million people worldwide were living with a diagnosis made in the past 5 years (IARC GLOBOCAN, 2022), and about 550,700 people in the United States were living with lung and bronchus cancer on January 1, 2021 (NCI SEER, 2024).
Overview
Respiratory system cancerSymptoms
Respiratory system cancer can cause a cough that does not go away, shortness of breath, chest pain, coughing up blood, and repeated chest infections. Early symptoms of respiratory system cancer may be subtle and can also include weight loss, tiredness, or hoarseness.
Outlook and prognosis
Outlook for respiratory system cancer varies widely by cancer type, stage, and overall health. When found early, treatment can sometimes control the cancer for years; advanced disease often needs ongoing care to ease symptoms and help people live longer.
Causes and risk factors
Respiratory system cancer risk rises most with smoking, secondhand smoke, radon, air pollution, and workplace exposures such as asbestos. Age, family history, and prior chest radiation can matter. Lung disease and heavy alcohol use may also raise risk.
Genetic influences
Genetics matter in respiratory system cancer, but most cases are not caused by a single inherited change. Some inherited variants can raise risk, and tumor gene changes often guide treatment choices.
Diagnosis
Respiratory system cancer is usually diagnosed after imaging tests such as a chest X-ray or CT scan show a suspicious area. Doctors confirm it with a biopsy. Blood tests and scans help stage the cancer and guide treatment.
Treatment and drugs
Treatment for respiratory system cancer depends on the cancer type, stage, and your overall health, and may include surgery, radiation, chemotherapy, targeted drugs, or immunotherapy. Many people also need help with breathing symptoms, pain, nutrition, and fatigue during treatment.
Symptoms
Respiratory system cancer can affect breathing, speech, and energy long before it is diagnosed. The changes are often subtle at first, blending into daily life until they become more noticeable. Many living with respiratory system cancer first notice a cough that does not go away, getting winded more easily, or a vague chest discomfort. Early symptoms of respiratory system cancer can overlap with infections, asthma, smoking-related lung disease, or even a lingering cold, so persistent or worsening changes deserve medical attention.
A cough that lasts for weeks, changes from your usual cough, or keeps you awake can be an early sign. For many people with respiratory system cancer, it starts as something easy to brush off, especially after a cold.
Even small streaks of blood or rust-colored mucus should be taken seriously. This can happen when a tumor irritates or damages the lining of the airways.
You may get winded more easily or notice a new wheeze during everyday activities like climbing stairs or carrying groceries. Respiratory system cancer can narrow the airways, reduce healthy lung space, or cause fluid around the lungs, making breathing feel harder.
Pain, pressure, or a dull ache in the chest, back, or shoulder can show up, especially with deep breaths, coughing, or laughing. Some may find it is constant, while others notice it mainly with movement or exertion.
How people usually first notice Respiratory system cancer?
Respiratory system cancer is often first noticed when a cough does not go away or starts changing, especially if it becomes more frequent, more painful, or brings up blood. Many people also first notice shortness of breath, chest pain, wheezing, repeated chest infections, or a new hoarse voice that lingers for weeks instead of improving. These symptoms are often caused by much more common, less serious problems, but if they persist or keep coming back, it is important to get them checked.
Types of Respiratory system cancer
Respiratory system cancer can affect the lungs, airways, or nearby lining of the chest, and the day-to-day impact often depends on the cancer type. In medical terms, these are called different types of respiratory system cancer, which describe how the cells behave and how quickly the cancer tends to grow. Symptoms do not always point clearly to one type, but some forms are more likely to cause a lingering cough, while others more often lead to chest pain, wheezing, or symptoms that worsen quickly.
Non-small cell
This is the most common group and it usually grows more slowly than small cell lung cancer. Many people with non-small cell disease notice a cough that does not go away, shortness of breath, chest discomfort, or coughing up blood. Symptoms may be mild at first, so some people feel well for quite a while before the cancer is found.
Small cell
This type tends to grow and spread faster, so symptoms can appear and worsen over a shorter time. People may develop a persistent cough, chest pain, shortness of breath, weight loss, or marked fatigue. It is also more likely than other lung cancers to cause whole-body effects, such as low energy or hormone-related symptoms.
Carcinoid tumors
These are less common and often grow more slowly than other lung cancers. Some people have repeated chest infections, wheezing, coughing, or cough up small amounts of blood, while others have very few symptoms at first. Having one type does not necessarily mean you will develop the others.
Mesothelioma
This cancer starts in the lining around the lungs rather than in the lung tissue itself. It more often causes chest pain, increasing shortness of breath, and fluid buildup around the lungs, which can make everyday activity feel harder. The symptoms can resemble other lung conditions, so it is sometimes recognized later.
Can I slow down the onset of symptoms?
Partly: there is good evidence that some steps can lower the risk of cancers in the lungs and airways, but there is no reliable proof that lifestyle changes can meaningfully delay symptoms once a cancer has already started. The best-supported factors are not smoking or quitting smoking, avoiding secondhand smoke, checking the home for radon, and limiting contact with asbestos, heavy dust, fumes, and polluted air; these steps may reduce risk, but they do not guarantee prevention. For people at high risk for lung cancer, regular low-dose CT screening, a special chest scan, can sometimes find cancer before symptoms begin, and taking these steps may help you stay healthier and catch problems earlier.
What genetics can tell you about symptoms
Genetics can sometimes help explain why respiratory system cancers behave differently from one person to another, including how fast they grow, which treatments may work, and in some cases when symptoms begin or how severe they become. Certain inherited gene changes can raise cancer risk, and changes inside the tumor itself can be linked with patterns such as earlier spread or more aggressive disease, but symptoms are still driven most often by where the cancer is in the lungs or airways and how advanced it is. For many living with respiratory system cancer, this means genetic results can add useful clues, but they usually cannot predict exact symptoms on their own.
Causes and risk factors
Smoking is the biggest cause of respiratory system cancer, and breathing secondhand smoke also raises risk. Other risk factors for respiratory system cancer include radon gas, asbestos, air pollution, diesel fumes, and some workplace chemicals. Risk also rises with older age, a history of chest radiation, and long-term lung disease such as COPD. Family history can matter too, because some people inherit gene changes that make lung cells more vulnerable to damage. It’s rarely just one factor—it’s the mix that matters, and quitting smoking can lower risk at any age.
What are the most common causes or risk factors?
The biggest risk factor for respiratory system cancer is smoking, including cigarettes, cigars, and pipes, and breathing in other people’s smoke can also raise risk. Other well-known risks include radon, a natural gas that can build up in homes, long-term exposure to air pollution or workplace substances such as asbestos, diesel exhaust, and certain chemicals, and older age. Some people also have a higher risk because of inherited gene changes or a strong family history, but most cases are linked more to harmful exposures than to genes alone.
Environmental and biological risk factors
Respiratory system cancer is more likely in some people because of a mix of body-based and outside exposures. Doctors often group risks into internal (biological) and external (environmental). Understanding environmental and biological risk factors for respiratory system cancer can help explain why risk differs from one person to another. Many people who develop these cancers have more than one risk factor, although some do not have a clear cause.
Breathing other people’s tobacco smoke over many years can damage the lining of the airways and lungs. This raises the risk of respiratory system cancer, especially when exposure happens regularly at home or work.
Radon is a radioactive gas that can build up indoors, often in basements and lower floors. You cannot see or smell it, and long-term exposure is a well-established cause of lung cancer.
Asbestos, silica dust, diesel exhaust, and some metal fumes can injure airway tissues over time. People working in mining, construction, shipyards, or heavy industry may face higher risk if exposure is repeated or poorly controlled.
Long-term exposure to fine particle pollution and traffic-related fumes can increase cancer risk in the lungs and airways. For one person the added risk may seem small, but it becomes more important when exposure lasts for years.
Genetic risk factors
When respiratory system cancer appears in several close relatives, it can raise understandable questions about inherited risk. Most cases are not caused by a single gene passed down in families, but some are linked to inherited changes that make cells less able to control growth or repair DNA. Understanding the genetic risk factors for respiratory system cancer can help families know when genetic counseling or earlier checks may be useful. Some risk factors are inherited through our genes.
Family history: Having a parent, sibling, or child with respiratory system cancer can raise your risk, especially if several relatives were affected or someone was diagnosed at a younger age. Family history does not always mean there is one specific inherited gene change, but it can be an important clue.
Inherited gene changes: Rare inherited changes in genes that control cell growth or DNA repair can increase the chance of cancer developing in the lungs or airways. Examples include changes in TP53 or RB1, and in rare families certain EGFR changes may also play a role.
Cancer syndromes: Some people inherit a broader cancer syndrome, where one gene change raises the risk of several cancers rather than just one. These syndromes are uncommon, but they are more likely to be considered when cancers cluster in a family or happen at unusually young ages.
Acquired DNA changes: Most respiratory system cancer starts after DNA changes develop in lung or airway cells over time. These changes are genetic, but they are not inherited and are usually not passed from a parent to a child.
Lifestyle risk factors
Several everyday habits can raise the chance of developing cancers in the respiratory system or can worsen outcomes after diagnosis. The most important lifestyle risk factors for respiratory system cancer involve tobacco exposure, alcohol use, diet, body weight, physical activity, and how consistently people follow prevention and treatment advice. Understanding how lifestyle affects respiratory system cancer can help people lower risk and support better lung health.
Cigarette smoking is the strongest lifestyle risk factor for respiratory system cancer because it repeatedly exposes airway cells to carcinogens. The risk rises with the number of cigarettes smoked and the number of years a person smokes.
Regular exposure to other people’s tobacco smoke can still damage the lining of the airways and increase cancer risk. Avoiding smoke at home, in cars, and in social settings can meaningfully reduce this exposure.
Cigars, pipes, and other tobacco products are not safe alternatives because they also deliver cancer-causing chemicals to the respiratory tract. Long-term use can increase the risk of cancers involving the mouth, throat, and lungs.
E-cigarettes may expose the airways to nicotine, ultrafine particles, and other potentially harmful chemicals that can promote chronic irritation. While the long-term cancer risk is still being studied, vaping should not be considered protective for respiratory health.
Risk prevention
For many, preventing respiratory system cancer starts with the air you breathe every day, the products you use, and whether you smoke or spend time around smoke. The biggest risk can often be lowered, especially by avoiding tobacco and reducing exposure to harmful fumes, dusts, and indoor pollutants. Prevention is about lowering risk, not eliminating it completely. Screening may also help some people at high risk find problems earlier, before early symptoms of respiratory system cancer appear.
Not smoking is the most effective way to lower the risk of respiratory system cancer. If you do smoke, quitting helps at any age, and the health benefits start within weeks to months.
Breathing other people's smoke over time can also raise the risk of respiratory system cancer. Making your home and car smoke-free lowers ongoing exposure for everyone around you.
Radon is a natural gas that can build up indoors, especially in basements and ground-floor rooms, and it is a known cause of lung cancer. Home testing is simple, and fixing high levels can meaningfully reduce risk.
Some jobs expose people to asbestos, diesel exhaust, silica, welding fumes, or other cancer-causing substances. Using proper ventilation and protective equipment, and following workplace safety rules, can lower the risk of respiratory system cancer.
Can you prevent Respiratory system cancer?
You cannot fully prevent respiratory system cancer, and some people develop it even without a clear cause. Still, many cases can be lowered by not smoking, avoiding secondhand smoke, testing your home for radon, and limiting exposure to harmful dust, fumes, and chemicals at work. If you smoke, quitting can help at any age, and using protective equipment on the job may also reduce risk.
Transmission
Respiratory system cancer is not contagious, so it cannot be transferred from one person to another by coughing, kissing, touching, sharing food, or being around someone who has it. For many, this is an important relief: you cannot catch respiratory system cancer the way you can catch a cold, flu, or COVID-19.
Most cases develop when cells in the lungs or airways are damaged over time, often from smoking, secondhand smoke, radon, air pollution, or certain workplace exposures. If you are wondering about how respiratory system cancer is inherited, a small number of cases may be linked to inherited risk, but it is usually not passed down directly in a simple parent-to-child pattern.
When to test your genes
Consider genetic testing if respiratory system cancer runs in your family, appears at a young age, or several relatives have related cancers. If you are diagnosed, tumor gene testing can help match treatment to the cancer’s specific changes, especially in lung cancer.
Diagnosis
Respiratory system cancer is often found after symptoms such as a cough that does not go away, coughing up blood, chest pain, or shortness of breath lead to a medical visit. Sometimes it is first spotted on a chest scan done for another reason. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of respiratory system cancer usually combines imaging tests, a close look at the airways or lungs, and a tissue sample to confirm the type of cancer.
Doctors ask about symptoms, smoking history, work exposures, past lung disease, and general health. A detailed family and health history can help show how likely cancer is and what other causes may need to be ruled out.
A clinician listens to the lungs, checks breathing, and looks for signs such as weight loss, swollen lymph nodes, or low oxygen levels. The exam cannot confirm cancer on its own, but it helps guide the next tests.
A chest X-ray may show a suspicious spot, fluid around the lung, or a collapsed area of lung. A CT scan gives a more detailed picture and is often a key step in how respiratory system cancer is diagnosed.
A PET scan can show areas of the body that are using more energy than expected, which may suggest active cancer. It is often used with CT to help judge how far the cancer may have spread.
How is Respiratory system cancer diagnosed?
Respiratory system cancer is usually diagnosed after a doctor reviews symptoms, listens to the chest, and orders imaging tests such as a chest X-ray or, more often, a CT scan, which gives a more detailed picture. If something suspicious is seen, the diagnosis is confirmed by taking a small sample of tissue or fluid from the lung or airways and checking it under a microscope; this may be done with a needle, during a scope test that looks inside the airways, or from coughed-up mucus in some cases. If cancer is found, the sample may also be tested for gene changes to help choose treatment, but the main diagnosis still depends on the scan results and the tissue sample.
Stages of Respiratory system cancer
Respiratory system cancer is often described in stages, based on how large the cancer is and whether it has spread to nearby tissue, lymph nodes, or farther parts of the body. The exact system can vary by where the cancer started, but many living with respiratory system cancer will hear stages numbered from 0 to IV. Early and accurate diagnosis helps you plan ahead with confidence. In general, the stages of respiratory system cancer help guide treatment and give a clearer sense of what doctors are treating.
Stage 0
Abnormal cells are found only in the top lining of the airway or lung tissue and have not grown deeper. This is the earliest stage and is sometimes called very early or in place cancer. It is usually found through scans, procedures, or testing done after early symptoms of respiratory system cancer or another concern.
Stage I
The cancer is small and stays in one area of the lung or nearby respiratory tissue. It has not spread to lymph nodes. Many people have few symptoms at this stage, and some find it is picked up on imaging done for another reason.
Stage II
The cancer is larger, has grown into nearby tissue, or has reached nearby lymph nodes. It is still considered limited enough that treatment may aim to remove or destroy all visible cancer. Symptoms such as cough, chest discomfort, or shortness of breath may become more noticeable.
Stage III
The cancer has spread more widely within the chest, often to lymph nodes in the middle of the chest or to nearby structures. Treatment is usually more complex and may combine surgery, radiation, and medicines. Sometimes answers come quickly, while other times it takes longer.
Stage IV
The cancer has spread outside the chest or to another part of the body, such as the liver, bones, brain, or the other lung. At this stage, treatment often focuses on slowing the cancer, easing symptoms, and helping people live as well as possible. The exact outlook can vary a lot depending on the cancer type and how it responds to treatment.
Outlook and prognosis
The outlook for respiratory system cancer varies widely depending on the exact cancer type, stage at diagnosis, how far it has spread, and the person’s overall health. Cancers found early and treated when still localized generally have a much better prognosis, while advanced or metastatic disease is associated with lower survival and a higher risk of recurrence. Lung cancer, which makes up most respiratory system cancers, remains one of the leading causes of cancer death worldwide, largely because many cases are diagnosed at a late stage. Survival has improved in recent years for some patients because of better imaging, earlier detection in high-risk groups, and more effective treatments such as targeted therapy, immunotherapy, surgery, radiation, and chemotherapy. Even so, mortality can still be substantial, especially for aggressive tumors or cancers that involve the central airways or spread beyond the chest. Regular follow-up is important, since prognosis can change over time based on treatment response, complications, and whether the cancer returns.
Long-term effects
Even after treatment, respiratory system cancer can have lasting effects on breathing, strength, and day-to-day comfort. The long-term picture is often shaped by the cancer type, stage, overall lung health, and the treatments used. People whose early symptoms of respiratory system cancer were found sooner may have fewer long-term problems than those diagnosed after the disease has spread.
Many people with respiratory system cancer have ongoing shortness of breath, cough, or reduced exercise tolerance after treatment. For many, this can mean getting winded on stairs, walking more slowly, or needing more rest during routine tasks.
One of the biggest long-term concerns is that respiratory system cancer can come back after a period of improvement. If it returns or spreads to places such as the brain, bones, or liver, it can cause new symptoms and shorten life expectancy.
Surgery, radiation, and drug treatment can leave lasting changes in the lungs, chest, throat, or nerves. Some effects may be scarring, chest discomfort, swallowing trouble, hearing changes, or numbness in the hands and feet.
Ongoing tiredness is common and can last months or longer, even when treatment has ended. Some may also lose muscle strength or stamina, making work, errands, and social activities harder to keep up with.
How is it to live with Respiratory system cancer?
Living with respiratory system cancer can reshape the rhythm of everyday life, often in ways that are both physical and emotional. Many people with this condition deal with symptoms such as shortness of breath, coughing, fatigue, pain, or reduced stamina, which can make walking, working, sleeping, eating, and even talking for long periods more difficult. It can also affect mood, independence, and plans for the future, while treatment schedules may place extra demands on daily routines. For family and close friends, this often means stepping into caregiving roles, helping with appointments and household tasks, and coping with worry of their own, so support usually works best when it includes both the person living with cancer and the people around them.
Treatment and drugs
Treatment for respiratory system cancer depends on where the cancer starts, how far it has spread, and the person’s overall health. Doctors may use one treatment or combine several, such as surgery to remove a tumor, radiation to target cancer cells, and medicines that travel through the body, including chemotherapy, targeted drugs, and immunotherapy. Treatment plans often combine several approaches. Some people with respiratory system cancer also need treatments to help breathing, ease pain, control cough, or prevent infections, because comfort and day-to-day function matter alongside treating the cancer itself. Not every treatment works the same way for every person, so care is usually adjusted over time based on side effects, test results, and how the cancer responds.
Can you cure Respiratory system cancer?
Some respiratory system cancers can be cured, especially if they are found early and treated before they spread, but many cannot be completely cured once they are more advanced. Even when a cure is not possible, treatment can still help by shrinking the cancer, slowing its growth, easing symptoms like cough or shortness of breath, and helping people live longer.
Non-drug treatment
Breathing, walking, eating, and even talking can become harder for people living with respiratory system cancer, so treatment often includes more than medicines alone. Depending on where the cancer is, its stage, and your overall health, care may involve procedures, radiation, rehabilitation, nutrition support, and emotional support. Managing this condition often means combining treatments that target the cancer with therapies that help you stay as strong and comfortable as possible. In some cases, the same team also helps with problems linked to the early symptoms of respiratory system cancer, such as cough, shortness of breath, weight loss, or fatigue.
Surgery may be used to remove part of the lung, an airway tumor, or nearby tissue if the cancer can be safely taken out. For many, this can mean easier breathing afterward, although recovery can take time and may temporarily limit daily activity.
Radiation uses focused high-energy beams to shrink or destroy cancer cells in the chest. It may be used on its own or alongside other treatments, especially when surgery is not the best option.
Pulmonary rehabilitation combines breathing training, safe exercise, and energy-saving skills to help people with respiratory system cancer do more with less breathlessness. Simple routines—like walking practice or guided breathing—can have lasting benefits.
Many living with respiratory system cancer lose weight or feel full quickly, so dietitian support can help you get enough calories and protein. This may make treatment easier to tolerate and help maintain strength.
Your genes may have an impact on how drugs work for you
For many people with respiratory system cancer, small differences in their own genes, and in the genes inside the cancer itself, can affect which medicines are most likely to help and which may be less likely to work. This is sometimes called pharmacogenomics, which simply means using gene information to help match treatment to the person, and in lung cancer especially, doctors often check the tumor for certain changes before choosing a targeted medicine. Some inherited gene differences can also affect how the body breaks down treatment, so one person may get strong benefit while another may have more side effects, which is why genetic testing can sometimes help guide care.
Pharmacological treatments
Medicines for respiratory system cancer are chosen based on the exact cancer type, stage, and whether the tumor has certain gene changes. Common options include chemotherapy, immunotherapy, targeted drugs, and a few medicines that block a tumor’s blood supply. The best drug treatment for respiratory system cancer often looks different from one person to another, even when two people have the same diagnosis. Not everyone responds to the same medication in the same way.
Cisplatin and carboplatin are core chemotherapy drugs for many lung and other respiratory cancers. They damage cancer cells directly and are often paired with another drug to improve results.
Pemetrexed, paclitaxel, docetaxel, and gemcitabine are commonly added to platinum drugs, especially for non-small cell lung cancer. The choice depends on the exact tumor type, overall health, and whether treatment is meant to shrink cancer, control it, or help after surgery.
Etoposide and irinotecan are widely used for small cell lung cancer, usually with cisplatin or carboplatin. If the cancer comes back, topotecan or lurbinectedin may also be used.
Pembrolizumab, nivolumab, atezolizumab, durvalumab, cemiplimab, and ipilimumab help the immune system recognize and attack cancer cells. These medicines are often used for advanced lung cancer and, in some cases, after chemoradiation or around the time of surgery.
Genetic influences
When respiratory system cancer shows up in more than one relative, many people start wondering whether their own risk is higher. It’s natural to ask whether family history plays a role. Genetics can affect respiratory system cancer risk, but for most people it is only part of the picture alongside smoking, secondhand smoke, air pollution, radon, asbestos, and other exposures. Some people inherit gene changes that make it harder for the body to repair DNA damage or handle harmful chemicals, which can raise the chance of cancer in the lungs or airways, especially when environmental risks are also present. Even so, most respiratory system cancer is not caused by a single inherited gene, so having a family history of respiratory system cancer does not mean you will definitely develop it. If several close relatives have had these cancers, or if they appeared at a younger age than usual, a doctor or genetic counselor may discuss whether inherited testing could be useful, while testing on the tumor itself can also help guide treatment choices.
Is Respiratory system cancer genetic?
Genetics matter in respiratory system cancer, but most cases are not caused by a single inherited change. Some inherited variants can raise risk, and tumor gene changes often guide treatment choices.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal part of human biology and are widespread across the general population. Most of these variants do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-understood variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many people living with respiratory system cancer, treatment is no longer chosen only by where the cancer started or how it looks on a scan. Doctors often test the cancer itself for gene changes because some changes can make targeted drugs much more likely to help, while others suggest that standard chemotherapy or immunotherapy may be a better fit. Genetic testing can sometimes identify how your body is likely to handle certain medicines, which may help explain why one drug causes strong side effects or does not work as expected. This can shape treatment in very practical ways, especially when doctors are choosing among options for drug treatment for respiratory system cancer. One person may do well on a standard dose, while another may need closer monitoring, a different drug, or dose changes to stay safe and get the best effect. Genetics is only one factor, so doctors also consider the exact cancer type, stage, other health conditions, and treatments you have already had when planning care for respiratory system cancer.
Interactions with other conditions
Respiratory system cancer often affects people who are also living with other long-term illnesses, especially chronic lung disease such as COPD, heart disease, and diabetes. Day-to-day, it can feel like one health issue amplifies the other: for example, someone who already gets short of breath from COPD may find that a lung tumor makes walking across a room or climbing stairs even harder. Infections such as pneumonia can also be more serious in people with respiratory system cancer, because the airways may already be blocked or irritated, and cancer treatment can sometimes weaken the body’s defenses. Blood clots are another important concern, since some cancers increase the risk of clots in the legs or lungs, which can suddenly worsen chest pain or breathing problems. Doctors also look closely at kidney and liver problems, because these can affect which treatments are safest and how well the body handles them. Early symptoms of respiratory system cancer can sometimes look like other common illnesses, including asthma, bronchitis, or heart failure, so careful follow-up is important when symptoms change or do not improve as expected.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Respiratory system cancer?
Several more common problems can look a lot like respiratory system cancer, including chest infections such as pneumonia or bronchitis, asthma, long-term smoking-related lung disease such as emphysema, tuberculosis, and sometimes a blood clot in the lung or heart failure. Because symptoms like a lasting cough, shortness of breath, chest pain, tiredness, weight loss, or coughing up blood can happen with more than one condition, doctors often need scans and other tests to tell the difference.
History
Long before scans and lab tests existed, people noticed that some illnesses caused a lasting cough, chest pain, weight loss, and trouble breathing that gradually worsened. Throughout history, people have described illnesses affecting the lungs and airways that, in hindsight, were likely forms of respiratory system cancer, although doctors at the time could not clearly tell one chest disease from another.
For centuries, understanding was limited because the lungs are hard to examine without surgery or imaging. Many cases were grouped with infections such as tuberculosis or with other causes of coughing up blood. In the 1800s and early 1900s, autopsies and improved microscopes helped doctors recognize that tumors could grow in the lungs, voice box, and other parts of the breathing system, and that these cancers looked different from one another under the microscope.
A major turning point came in the 20th century, when cigarette use rose sharply and doctors began seeing many more cases of lung cancer. Over time, large studies showed a strong link between smoking and respiratory system cancer, changing both medical care and public health. Later, researchers also confirmed that other exposures, such as secondhand smoke, asbestos, radon gas, air pollution, and some workplace chemicals, can raise risk.
The history of respiratory system cancer also changed as technology improved. Chest X-rays first helped doctors spot suspicious masses, and later CT scans made it easier to find smaller tumors and see how far a cancer had spread. Bronchoscopy, biopsy, and modern lab testing then allowed doctors to identify the exact type more accurately, which matters because treatment can differ a lot between cancers that start in the lungs and those that begin in the voice box or other nearby tissues.
In recent decades, care has continued to shift. People living with respiratory system cancer may now hear about surgery, radiation, chemotherapy, targeted treatments, and immunotherapy, options that were not available to earlier generations. This does not make the condition simple or easy, but it does mean that early symptoms of respiratory system cancer are taken more seriously than in the past, and more people can be diagnosed sooner and offered treatment tailored to their cancer type.